Syphilis Surveillance in Portugal, 2000-2005 by Coelho, R et al.
Gaithersburg, MD, USA) and demonstrated a known het-
erozygous trinucleotide deletion c.389_391delCCT (caus-
ing p.Ser130del) in exon 1 of the KRT16 gene.
The combination of pachyonychia congenita type I and
the above-mentioned unusual skeletal malformation has
not been previously described. It is tempting to speculate
that the abnormalities are not coincidental. As it seems
biologically implausible that a KRT16 mutation could
affect skeletal development, one might assume the exis-
tence of a contiguous gene syndrome. However, that is
unlikely as we found a trinucleotide deletion in the
KRT16 gene for which the patient is clearly heterozygous,
thus ruling out microdeletions encompassing all or part of
KRT16. It is therefore more prudent to assume that there is
no causal relationship. It is even debatable whether the
skeletal abnormality is genetically determined, as it cannot
be classified into one of the known categories of acral
developmental abnormalities. Thus, we think that the con-
currence we describe is a coincidental one. It is, however,
quite possible that the abnormal skeleton can contribute to
the pachyonychia and concomitant keratoderma by alter-
ing pressure distribution.
We also suggest that the other skeletal defects that have
been reported in association with pachyonychia type I
were not causally related. The relatively high frequency
in the literature may be due to an ascertainment bias. ■
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Syphilis surveillance in Portugal,
2000-2005
The annual incidence of acquired syphilis in developed
countries dropped to very low levels in the early 1990s,
partly due to aggressive HIV campaigns that emphasized
condom use. However, a series of syphilis outbreaks have
been reported in several northern and western European
countries since 1996. These outbreaks have disproportion-
ately involved men who have sex with men (MSM), peo-
ple who engage in high-risk sexual behavior (e.g., unpro-
tected sex with prostitutes or multiple partners), and
people who use new recreational drugs [1]. The purpose
of this paper is to analyze the syphilis trends from 2000 to
2005 in Portugal based on data collected by the Sentinel
Network for Sexually Transmitted Infections (STIs) Sur-
veillance.
Operating since 2000, the Sentinel Network System was
established to collect data on all STIs in Portugal. It
involves eight public hospitals and health-center based
STI clinics that cover about 70% of the Portuguese popu-
lation, relies on voluntary participating dermatovenereol-
ogists and receives self-referred and physician-referred
patients. From 2000 to 2005, 5,020 cases of Sexually
Transmitted Infections were reported by this Sentinel Net-
work System and Syphilis testing was routinely offered to
all patients.
The organization aims to determine STI incidence trends
and to monitor epidemiological profiles of STI patients.
Syphilis notifications contain information on gender, resi-
dence, sexual orientation, country of birth, HIV status,
educational level attained, number of sexual partners dur-
ing the last six months, intravenous drug and condom use
habits. Data security and strict patient confidentiality are
always maintained. The data presented in this paper
include infectious syphilis cases (primary, secondary and
early latent) reported between January 2000 and Decem-
ber 2005. Statistical analyses were performed with SPSS®
v.13.0. Proportions were compared using the Chi-square
test.
From 2000 to 2005, 784 cases of recent syphilis were




Figure 1. A, B) Clinical phenotype of the feet (A, right foot;
B, left foot); C) radiograph of the normal left hand; D) sub-
ungual hyperkeratosis and keratoderma of the sole consistent
with a diagnosis of pachyonychia type I; E, F) skeletal radio-
graphs showing unclassifiable dysplasia.
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reported in 2000, 149 in 2001, 115 in 2002, 122 in 2003,
91 in 2004 and 99 in 2005. Although the increase from 91
to 99 cases from 2004 to 2005 was not statistically signif-
icant, it is worth noting that it was linked to a syphilis
outbreak that occurred in 2005 among MSM. Indeed,
from 2000 and 2005, the proportion of syphilis cases
involving MSM increased (p < 0.001), while that involv-
ing females and heterosexual men decreased and remained
stable, respectively (figure 1). Of the 767 syphilis cases
with HIV status data, 136 (17.3%) were HIV-positive,
including 51 patients who received their HIV and syphilis
diagnoses concurrently and 85 who had previously been
diagnosed as HIV-positive. HIV prevalence was 43.3% in
MSM, 11.3% in heterosexual men, and 10.8% in females.
There was a general increase in the number of HIV-
positive patients in Portugal after 2002 (p < 0.001).
The Sentinel Network data indicate a selective increase in
syphilis infections in MSM since 2000, while the number
of heterosexually transmitted cases remained relatively
stable. However, the proportion of heterosexually trans-
mitted cases was relatively large for Western Europe.
The frequent occurrence of syphilis and HIV co-
infection is of great concern; these patients are also at
risk for gonorrhea, chlamydia infections and L2 chla-
mydia proctitis [2-4]. Media coverage, syphilis-
awareness advertisements in the gay media and distribu-
tion of literature to the homosexual community are evi-
dently insufficient to contain syphilis spreading among
MSM in Portugal.
In conclusion, there has been a surge in syphilis rates in
many Western countries since the late 1990s. However,
this trend only emerged in Portugal the past few years.
This review of syphilis cases between 2000 and 2005
shows similar findings to epidemiological trends in other
European countries. Syphilis screening should be empha-
sized for MSM, especially for those being treated for HIV.
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Contact dermatitis from an anti-
haemorroidal cream containing
ruscogenin
Ruscus aculeatus L. is a member of the Liliaceae family
and is native to Mediterranean Europe and Africa. It has
been widely used as a laxative and diuretic agent and as a
vasoconstrictor in the topical treatment of varices and hae-
morrhoids. The pharmacological activity of Ruscus acu-
leatus L. is attributed to steroidal saponins, mainly rusco-
genin (figure 1) and neoruscogenin, which have
venoconstricting and antiinflammatory effects [1, 2].
A 35-year-old man presented with pruritic erythematous
lesions on the perianal area and buttocks 5 days after ini-
tiating the local application of Ruscus Llorens® (Llorens,
Barcelona, Spain) cream for haemorrhoids. The lesions
became papulo-erythematous, well-defined and spread
within a day to the trunk and both legs.
The patient had used other antihaemorrhoidal creams pre-
viously with no cutaneous reactions. Therapy with the
cream was stopped and the patient was successfully trea-
ted with oral corticosteroids.
The antihaemorrhoidal cream contained ruscogenin,
cinchocaine hydrochloride (dibucaine), prednisolone,
menthol, zinc oxide and other excipients in its composi-
tion. The patient was patch tested with GEIDAC (Spanish
Group of Investigation of Contact Dermatitis) standard
series, local anaesthetics series and Ruscus llorens®
cream as is. Caine mix, tixocortol pivalate, Ruscus
llorens® cream, and cinchocaine patch tests were positive
(++) at 48 and 96 hours, and tetracaine (++) and lidocaine
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Figure 1. Chemical structure of ruscogenin.
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